Abeler, V. M., Røyne, O., Thoresen, S., Danielsen, H. E., Nesland, J. M., & Kristensen, G. B. (2009). Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology, 54(3), 355-364.
Aisen, A. M., Martel, W., Braunstein, E. M., McMillin, K. I., Phillips, W. A., & Kling, T. F. (1986). MRI and CT evaluation of primary bone and soft-tissue tumors. AJR Am J Roentgenol, 146(4), 749-756.
Aksnes, L. H. (2008). Health in long-term survivors of bone sarcoma (Doktorgrad). Oslo: Faculty of Medicine, University of Oslo Unipub.
Al-Absi, E., Farrokhyar, F., Sharma, R., Whelan, K., Corbett, T., Patel, M., & Ghert, M. (2010). A systematic review and meta-analysis of oncologic outcomes of pre- versus postoperative radiation in localized resectable soft-tissue sarcoma. Ann Surg Oncol, 17(5), 1367-1374.
Albertsmeier, M., Rauch, A., Roeder, F., Hasenhütl, S., Pratschke, S., Kirschneck, M., . . . Angele, M. K. (2018). External Beam Radiation Therapy for Resectable Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis. Ann Surg Oncol, 25(3), 754-767. https://doi.org/10.1245/s10434-017-6081-2
Alektiar, K. M., Brennan, M. F., Healey, J. H., & Singer, S. (2008). Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity. J Clin Oncol, 26(20), 3440-3444.
Alektiar, K. M., Velasco, J., Zelefsky, M. J., Woodruff, J. M., Lewis, J. J., & Brennan, M. F. (2000). Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity. Int J Radiat Oncol Biol Phys, 48(4), 1051-1058.
Allen, A. M., Pawlicki, T., Dong, L., Fourkal, E., Buyyounouski, M., Cengel, K., . . . Konski, A. A. (2012). An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee. Radiother Oncol, 103(1), 8-11. https://doi.org/10.1016/j.radonc.2012.02.001
Alyas, F., James, S. L., Davies, A. M., & Saifuddin, A. (2007). The role of MR imaging in the diagnostic characterisation of appendicular bone tumours and tumour-like conditions. Eur Radiol, 17(10), 2675-2686.
Andreassen, A., Øyjord, T., Hovig, E., Holm, R., Flørenes, V. A., Nesland, J. M., . . . Børresen, A. L. (1993). p53 abnormalities in different subtypes of human sarcomas. Cancer Research, 53(3), 468-471.
Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., . . . Preiser, J. C. (2017). ESPEN guidelines on nutrition in cancer patients. Clin Nutr, 36(1), 11-48. https://doi.org/10.1016/j.clnu.2016.07.015
Arlen, M., Higinbotham, N. L., Huvos, A. G., Marcove, R. C., Miller, T., & Shah, I. C. (1971). Radiation-induced sarcoma of bone. Cancer, 28(5), 1087-1099.
Bauer, H. C., Trovik, C. S., Alvegard, T. A., Berlin, O., Erlanson, M., Gustafson, P., . . . Wiklund, T. (2001). Monitoring referral and treatment in soft tissue sarcoma: study based on 1,851 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand, 72(2), 150-159.
Becher, S., & Oskouei, S. (2015). PET Imaging in Sarcoma. Orthopedic Clinics of North America, 46(3), 409-415, xi. https://doi.org/10.1016/j.ocl.2015.03.001
Berger-Richardson, D., & Swallow, C. J. (2017). Needle tract seeding after percutaneous biopsy of sarcoma: Risk/benefit considerations. Cancer, 123(4), 560-567. https://doi.org/10.1002/cncr.30370
Berner, K., Johannesen, T. B., Berner, A., Haugland, H. K., Bjerkehagen, B., Bøhler, P. J., & Bruland, O. S. (2015). Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma. Acta Oncologica, 54(1), 25-33.
Berquist, T. H., Ehman, R. L., King, B. F., Hodgman, C. G., & Ilstrup, D. M. (1990). Value of MR imaging in differentiating benign from malignant soft-tissue masses: study of 95 lesions. AJR Am J Roentgenol, 155(6), 1251-1255.
Bhangu, A. A., Beard, J. A., & Grimer, R. J. (2004). Should soft tissue sarcomas be treated at a specialist centre? Sarcoma, 8(1), 1-6.
Bielack, S. S., & Carrle, D. (2008). State-of-the-art approach in selective curable tumors: bone sarcoma. Ann Oncol, 19 Suppl 7, vii155-vii160.
Bielack, S. S., Smeland, S., Whelan, J. S., Marina, N., Jovic, G., Hook, J. M., . . . investigators, E.-. (2015). Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial. Journal of Clinical Oncology, 33(20), 2279-2287.
Bischof, D. A., Kim, Y., Dodson, R., Jimenez, M. C., Behman, R., Cocieru, A., . . . Pawlik, T. M. (2015). Conditional disease-free survival after surgical resection of gastrointestinal stromal tumors: a multi-institutional analysis of 502 patients. JAMA Surg, 150(4), 299-306. https://doi.org/10.1001/jamasurg.2014.2881
Bjerkehagen, B., Smeland, S., Walberg, L., Skjeldal, S., Hall, K. S., Nesland, J. M., . . . Saeter, G. (2008). Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital. Acta oncologica (Stockholm, Sweden), 47(8), 1475-1482.
Blanchard, D. K., Reynolds, C., Grant, C. S., Farley, D. R., & Donohue, J. H. (2002). Radiation-induced breast sarcoma. Am J Surg, 184(4), 356-358.
Blay, J. Y., Serrano, C., Heinrich, M. C., Zalcberg, J., Bauer, S., Gelderblom, H., . . . von Mehren, M. (2020). Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial. The Lancet. Oncology, 21(7), 923-934. https://doi.org/10.1016/s1470-2045(20)30168-6
Bonvalot, S., Gronchi, A., Le Péchoux, C., Swallow, C. J., Strauss, D., Meeus, P., . . . Haas, R. L. (2020). Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. The Lancet. Oncology, 21(10), 1366-1377. https://doi.org/10.1016/s1470-2045(20)30446-0
Bonvalot, S., Rivoire, M., Castaing, M., Stoeckle, E., Le Cesne, A., Blay, J. Y., & Laplanche, A. (2009). Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol, 27(1), 31-37. https://doi.org/10.1200/jco.2008.18.0802
Bosma, S. E., Cleven, A. H. G., & Dijkstra, P. D. S. (2019). Can Navigation Improve the Ability to Achieve Tumor-free Margins in Pelvic and Sacral Primary Bone Sarcoma Resections? A Historically Controlled Study. Clin Orthop Relat Res, 477(7), 1548-1559. https://doi.org/10.1097/corr.0000000000000766
Boye, K., Del Prever, A. B., Eriksson, M., Saeter, G., Tienghi, A., Lindholm, P., . . . Hall, K. S. (2014). High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II study. Pediatric blood & cancer, 61(5), 840-845. https://doi.org/10.1002/pbc.24868
Brennan, M. F., Antonescu, C. R., Moraco, N., & Singer, S. (2014). Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Ann Surg, 260(3), 416-421; discussion 421-412. https://doi.org/10.1097/sla.0000000000000869
Brenner, D. J., Curtis, R. E., Hall, E. J., & Ron, E. (2000). Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer, 88(2), 398-406.
Cahan, W. G., Woodard, H. Q., Higinbotham, N. L., Stewart, F. W., & Coley, B. L. (1998). Sarcoma arising in irradiated bone: report of eleven cases. 1948. Cancer, 82(1), 8-34.
Canter, R. J., Qin, L. X., Ferrone, C. R., Maki, R. G., Singer, S., & Brennan, M. F. (2008). Why do patients with low-grade soft tissue sarcoma die? Ann Surg Oncol, 15(12), 3550-3560.
Casali, P. G., Blay, J. Y., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., . . . Stacchiotti, S. (2022). Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 33(1), 20-33. https://doi.org/10.1016/j.annonc.2021.09.005
Cha, C., Antonescu, C. R., Quan, M. L., Maru, S., & Brennan, M. F. (2004). Long-term results with resection of radiation-induced soft tissue sarcomas. Ann Surg, 239(6), 903-909.
Chen, L., Wu, X., Ma, X., Guo, L., Zhu, C., & Li, Q. (2017). Prognostic value of 18F-FDG PET-CT-based functional parameters in patients with soft tissue sarcoma: A meta-analysis. Medicine (Baltimore), 96(6), e5913. https://doi.org/10.1097/md.0000000000005913
Chouliaras, K., Senehi, R., Ethun, C. G., Poultsides, G., Grignol, V., Clarke, C. N., . . . Votanopoulos, K. I. (2019). Role of radiation therapy for retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative. Journal of Surgical Oncology, 120(7), 1227-1234. https://doi.org/10.1002/jso.25694
Ciernik, I. F., Niemierko, A., Harmon, D. C., Kobayashi, W., Chen, Y. L., Yock, T. I., . . . Delaney, T. F. (2011). Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma. Cancer, 117(19), 4522-4530. https://doi.org/10.1002/cncr.26037
College of American Pathologists. (2012). [nettside]. Northfield, IL: CAP. Hentet 2012, fra www.cap.org/
Constantinidou, A., Jones, R. L., Olmos, D., Thway, K., Fisher, C., Al-Muderis, O., & Judson, I. (2012). Conventional anthracycline-based chemotherapy has limited efficacy in solitary fibrous tumour. Acta oncologica (Stockholm, Sweden), 51(4), 550-554. https://doi.org/10.3109/0284186x.2011.626450
Cramp, F., & Daniel, J. (2008). Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev, (2), CD006145.
D'Ambrosio, L., Touati, N., Blay, J. Y., Grignani, G., Flippot, R., Czarnecka, A. M., . . . Gronchi, A. (2020). Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Cancer, 126(11), 2637-2647. https://doi.org/10.1002/cncr.32795
D'Angelo, S. P., Mahoney, M. R., Van Tine, B. A., Atkins, J., Milhem, M. M., Jahagirdar, B. N., . . . Streicher, H. (2018). Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials. The Lancet. Oncology, 19(3), 416-426. https://doi.org/10.1016/s1470-2045(18)30006-8
Daisne, J. F., Duprez, T., Weynand, B., Lonneux, M., Hamoir, M., Reychler, H., & Gregoire, V. (2004). Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology, 233(1), 93-100.
Dangoor, A., Seddon, B., Gerrand, C., Grimer, R., Whelan, J., & Judson, I. (2016). UK guidelines for the management of soft tissue sarcomas. Clinical sarcoma research, 6, 20. https://doi.org/10.1186/s13569-016-0060-4
Davis, A. M., O'Sullivan, B., Turcotte, R., Bell, R., Catton, C., Chabot, P., . . . Trial, N. C. I. C. C. T. G. R. (2005). Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiotherapy and Oncology, 75(1), 48-53.
Davis, L. E., Bolejack, V., Ryan, C. W., Ganjoo, K. N., Loggers, E. T., Chawla, S., . . . Maki, R. G. (2019). Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma. J Clin Oncol, 37(16), 1424-1431. https://doi.org/10.1200/jco.18.02374
DeMatteo, R. P., Lewis, J. J., Leung, D., Mudan, S. S., Woodruff, J. M., & Brennan, M. F. (2000). Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg, 231(1), 51-58.
Demetri, G. D., Reichardt, P., Kang, Y. K., Blay, J. Y., Rutkowski, P., Gelderblom, H., . . . Casali, P. G. (2013). Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet, 381(9863), 295-302. https://doi.org/10.1016/s0140-6736(12)61857-1
Demetri, G. D., Schöffski, P., Grignani, G., Blay, J. Y., Maki, R. G., Van Tine, B. A., . . . Chawla, S. (2017). Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine. J Clin Oncol, Aug 30 [Epub ahead of print]. https://doi.org/10.1200/jco.2016.71.6605
Demetri, G. D., van Oosterom, A. T., Garrett, C. R., Blackstein, M. E., Shah, M. H., Verweij, J., . . . Casali, P. G. (2006). Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet, 368(9544), 1329-1338.
Demetri, G. D., von Mehren, M., Jones, R. L., Hensley, M. L., Schuetze, S. M., Staddon, A., . . . Patel, S. R. (2016). Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial. J Clin Oncol, 34(8), 786-793. https://doi.org/10.1200/jco.2015.62.4734
Demizu, Y., Jin, D., Sulaiman, N. S., Nagano, F., Terashima, K., Tokumaru, S., . . . Okimoto, T. (2017). Particle Therapy Using Protons or Carbon Ions for Unresectable or Incompletely Resected Bone and Soft Tissue Sarcomas of the Pelvis. International Journal of Radiation Oncology, Biology, Physics, 98(2), 367-374.
Di Brina, L., Fogliata, A., Navarria, P., D'Agostino, G., Franzese, C., Franceschini, D., . . . Scorsetti, M. (2019). Adjuvant volumetric modulated arc therapy compared to 3D conformal radiation therapy for newly diagnosed soft tissue sarcoma of the extremities: outcome and toxicity evaluation. British Journal of Radiology, 92(1102), 20190252. https://doi.org/10.1259/bjr.20190252
Dickie, C. I., Haas, R., & O'Sullivan, B. (2015). Adjuvant radiation for soft tissue sarcomas. Am Soc Clin Oncol Educ Book, e634-642. https://doi.org/10.14694/EdBook_AM.2015.35.e634
Dirksen, U., Brennan, B., Le Deley, M. C., Cozic, N., van den Berg, H., Bhadri, V., . . . Hawkins, D. S. (2019). High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008. J Clin Oncol, 37(34), 3192-3202. https://doi.org/10.1200/jco.19.00915
Duffaud, F., Mir, O., Boudou-Rouquette, P., Piperno-Neumann, S., Penel, N., Bompas, E., . . . Blay, J. Y. (2019). Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study. The Lancet. Oncology, 20(1), 120-133. https://doi.org/10.1016/s1470-2045(18)30742-3
Dyrop, H. B., Vedsted, P., Safwat, A., Maretty-Nielsen, K., Hansen, B. H., Jørgensen, P. H., . . . Keller, J. (2014). Alarm symptoms of soft-tissue and bone sarcoma in patients referred to a specialist center. Acta Orthopaedica, 85(6), 657-662.
Eggermont, A. M., de Wilt, J. H., & ten Hagen, T. L. (2003). Current uses of isolated limb perfusion in the clinic and a model system for new strategies. Lancet Oncology, 4(7), 429-437.
Elvsaas, I.-K. Ø., Graff, B. A., Harboe, I., & Norderhaug, I. N. (2008). Kompresjonsstrømper i forebygging av dyp venetrombose (Rapport fra Kunnskapssenteret nr. 28). Oslo: Nasjonalt kunnskapsenter for helsetjenesten. Hentet fra https://www.fhi.no/publ/eldre/kompresjonsstromper-i-forebygging-av-dyp-venetrombose-/
Emami, B., Lyman, J., Brown, A., Coia, L., Goitein, M., Munzenrider, J. E., . . . Wesson, M. (1991). Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys, 21(1), 109-122.
Emile, J. F., Brahimi, S., Coindre, J. M., Bringuier, P. P., Monges, G., Samb, P., . . . Aegerter, P. (2012). Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs. Medical Oncology, 29(3), 1765-1772. https://doi.org/10.1007/s12032-011-0074-y
Eng, C., Li, F. P., Abramson, D. H., Ellsworth, R. M., Wong, F. L., Goldman, M. B., . . . Boice, J. D., Jr. (1993). Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst, 85(14), 1121-1128.
Engström, K., Bergh, P., Cederlund, C. G., Hultborn, R., Willen, H., Aman, P., . . . Meis-Kindblom, J. M. (2007). Irradiation of myxoid/round cell liposarcoma induces volume reduction and lipoma-like morphology. Acta oncologica (Stockholm, Sweden), 46(6), 838-845. https://doi.org/10.1080/02841860601080415
Enneking, W. F., Spanier, S. S., & Goodman, M. A. (1980). A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res, (153), 106-120.
Eriksson, M. (2010). Histology-driven chemotherapy of soft-tissue sarcoma. Ann Oncol, 21 Suppl 7, vii270-276. https://doi.org/10.1093/annonc/mdq285
Eriksson, M., Reichardt, P., Sundby Hall, K., Schütte, J., Cameron, S., Hohenberger, P., . . . Joensuu, H. (2016). Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour - Does it increase the risk for tumour cell seeding and recurrence? Eur J Cancer, 59, 128-133. https://doi.org/10.1016/j.ejca.2016.02.021
Euramos 1. Randomised trial of the European and American osteosarcoma study group to optimise treatment strategies for resectable osteosarcoma based on histological response to pre-operative chemotherapy. (2012). European and American Osteosarcoma Study Group. Hentet fra http://www.ctu.mrc.ac.uk/euramos/euramos_i_trial.asp
Evrard, R., Schubert, T., Paul, L., & Docquier, P. L. (2019). Resection margins obtained with patient-specific instruments for resecting primary pelvic bone sarcomas: A case-control study. Orthopaedics & Traumatology, Surgery & Research, 105(4), 781-787. https://doi.org/10.1016/j.otsr.2018.12.016
Expert Panel on Musculoskeletal, I., Bestic, J. M., Wessell, D. E., Beaman, F. D., Cassidy, R. C., Czuczman, G. J., . . . Kransdorf, M. J. (2020). ACR Appropriateness Criteria(R) Primary Bone Tumors. J Am Coll Radiol, 17(5S), S226-S238. https://doi.org/10.1016/j.jacr.2020.01.038
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma (FaR-RMS). (2020-2030). [pågående studie]. (NCT04625907). Hentet fra https://clinicaltrials.gov/ct2/show/NCT04625907
Fein, D. A., Lee, W. R., Lanciano, R. M., Corn, B. W., Herbert, S. H., Hanlon, A. L., . . . Coia, L. R. (1995). Management of extremity soft tissue sarcomas with limb-sparing surgery and postoperative irradiation: do total dose, overall treatment time, and the surgery-radiotherapy interval impact on local control? Int J Radiat Oncol Biol Phys, 32(4), 969-976.
Feinberg, L., Srinivasan, A., Singh, J. K., Parry, M., Stevenson, J., Jeys, L., . . . Desai, A. (2018). Impact of specialist management on survival from radiation-associated angiosarcoma of the breast. British Journal of Surgery, 105(4), 401-409. https://doi.org/10.1002/bjs.10696
Fendler, W. P., Chalkidis, R. P., Ilhan, H., Knosel, T., Herrmann, K., Issels, R. D., . . . Hacker, M. (2015). Evaluation of several FDG PET parameters for prediction of soft tissue tumour grade at primary diagnosis and recurrence. Eur Radiol, 25(8), 2214-2221. https://doi.org/10.1007/s00330-015-3654-y
Ferrari, A., van Noesel, M. M., Brennan, B., Zanetti, I., Corradini, N., Casanova, M., . . . Orbach, D. (2021). Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG). Lancet Child Adolesc Health, 5(8), 546-558. https://doi.org/10.1016/s2352-4642(21)00159-0
Ferrari, S., Bielack, S. S., Smeland, S., Longhi, A., Egerer, G., Sundby Hall, K., . . . Reichardt, P. (2018). EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma. Tumori, 104(1), 30-36. https://doi.org/10.5301/tj.5000696
Ferrari, S., Smeland, S., Mercuri, M., Bertoni, F., Longhi, A., Ruggieri, P., . . . Scandinavian Sarcoma, G. (2005). Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. Journal of Clinical Oncology, 23(34), 8845-8852.
Ferrari, S., Sundby Hall, K., Luksch, R., Tienghi, A., Wiebe, T., Fagioli, F., . . . Smeland, S. (2011). Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol. Annals of Oncology, 22(5), 1221-1227.
Ferraro, D., & Zalcberg, J. (2014). Regorafenib in gastrointestinal stromal tumors: clinical evidence and place in therapy. Therapeutic advances in medical oncology, 6(5), 222-228. https://doi.org/10.1177/1758834014544892
Fletcher, C. D., Berman, J. J., Corless, C., Gorstein, F., Lasota, J., Longley, B. J., . . . Weiss, S. W. (2002). Diagnosis of gastrointestinal stromal tumors: a consensus approach. International Journal of Surgical Pathology, 10(2), 81-89.
Forskrift om prioritering av helsetjenester, rett til nødvendig helsehjelp fra spesialisthelsetjenesten, rett til behandling i utlandet og om klagenemnd (prioriteringsforskriften). FOR-2000-12-01-1208. Sist endret i FOR-2021-10-08-2958 fra 01.11.2021. Hentet fra https://lovdata.no/dokument/SF/forskrift/2000-12-01-1208
Frustaci, S., Gherlinzoni, F., De, P. A., Bonetti, M., Azzarelli, A., Comandone, A., . . . Picci, P. (2001). Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol, 19(5), 1238-1247.
Fuglø, H. M., Jørgensen, S. M., Loft, A., Hovgaard, D., & Petersen, M. M. (2012). The diagnostic and prognostic value of (1)(8)F-FDG PET/CT in the initial assessment of high-grade bone and soft tissue sarcoma. A retrospective study of 89 patients. European journal of nuclear medicine and molecular imaging, 39(9), 1416-1424. https://doi.org/10.1007/s00259-012-2159-z
Gannon, N. P., King, D. M., Ethun, C. G., Charlson, J., Tran, T. B., Poultsides, G., . . . Bedi, M. (2019). The role of radiation therapy and margin width in localized soft-tissue sarcoma: Analysis from the US Sarcoma Collaborative. Journal of Surgical Oncology, 120(3), 325-331. https://doi.org/10.1002/jso.25522
Garcia del Muro, X. (2015). Nilotinib, imatinib, and GIST therapy. Lancet Oncology, 16(5), 483-484.
Gastrointestinal Stromal Tumor Meta-Analysis Group (MetaGIST). (2010). Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients. J Clin Oncol, 28(7), 1247-1253. https://doi.org/10.1200/jco.2009.24.2099
Gerbers, J. G., Stevens, M., Ploegmakers, J. J., Bulstra, S. K., & Jutte, P. C. (2014). Computer-assisted surgery in orthopedic oncology. Acta Orthopaedica, 85(6), 663-669.
Gerrand, C., Athanasou, N., Brennan, B., Grimer, R., Judson, I., Morland, B., . . . British Sarcoma, G. (2016). UK guidelines for the management of bone sarcomas. Clinical sarcoma research, 6, 7. https://doi.org/10.1186/s13569-016-0047-1
Gerrand, C. H., Bell, R. S., Wunder, J. S., Kandel, R. A., O'Sullivan, B., Catton, C. N., . . . Davis, A. M. (2003). The influence of anatomic location on outcome in patients with soft tissue sarcoma of the extremity. Cancer, 97(2), 485-492.
Gielen, J. L., De Schepper, A. M., Vanhoenacker, F., Parizel, P. M., Wang, X. L., Sciot, R., & Weyler, J. (2004). Accuracy of MRI in characterization of soft tissue tumors and tumor-like lesions. A prospective study in 548 patients. Eur Radiol, 14(12), 2320-2330.
Giraudet-Le Quintrec, J. S., Coste, J., Vastel, L., Pacault, V., Jeanne, L., Lamas, J. P., . . . Courpied, J. P. (2003). Positive effect of patient education for hip surgery: a randomized trial. Clin Orthop Relat Res, (414), 112-120.
Goldblum, J. R., Weiss, S. W., & Folpe, A. L. (2019). Enzinger and Weiss's soft tissue tumors (7. utg.). Philadelphia: Mosby Elsevier.
Gomarteli, K., Fleckenstein, J., Kirschner, S., Bobu, V., Brockmann, M. A., Henzler, T., . . . Giordano, F. A. (2019). Radiation-induced malignancies after intensity-modulated versus conventional mediastinal radiotherapy in a small animal model. Scientific Reports, 9(1), 15489. https://doi.org/10.1038/s41598-019-51735-3
Griffith, J. F., Yip, S. W. Y., Hung, E. H. Y., Fong, R. C. W., Leung, J., Ng, A. W. H., . . . Lee, R. K. L. (2020). Accuracy of ultrasound in the characterisation of deep soft tissue masses: a prospective study. Eur Radiol, 30(11), 5894-5903. https://doi.org/10.1007/s00330-020-07002-5
Grimer, R. J., Carter, S. R., Tillman, R. M., & Abudu, A. (2001). Early symptoms and diagnosis of bone tumors. J Bone Joint Surg Am, 83-A(7), 1107-1108.
Grimer, R. J., & Sneath, R. S. (1990). Diagnosing malignant bone tumours. J Bone Joint Surg Br, 72(5), 754-756.
Gronchi, A., Bonvalot, S., Poveda Velasco, A., Kotasek, D., Rutkowski, P., Hohenberger, P., . . . Casali, P. G. (2020). Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib. JAMA Surg, 155(6), e200397. https://doi.org/10.1001/jamasurg.2020.0397
Gronchi, A., Lo Vullo, S., Fiore, M., Mussi, C., Stacchiotti, S., Collini, P., . . . Casali, P. G. (2009). Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol, 27(1), 24-30. https://doi.org/10.1200/jco.2008.17.8871
Gronchi, A., Miah, A. B., Dei Tos, A. P., Abecassis, N., Bajpai, J., Bauer, S., . . . Stacchiotti, S. (2021). Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up(☆). Ann Oncol, 32(11), 1348-1365. https://doi.org/10.1016/j.annonc.2021.07.006
Gronchi, A., Miceli, R., Allard, M. A., Callegaro, D., Le Péchoux, C., Fiore, M., . . . Bonvalot, S. (2015). Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection. Ann Surg Oncol, 22(5), 1447-1454. https://doi.org/10.1245/s10434-014-4130-7
Gronchi, A., Palmerini, E., Quagliuolo, V., Martin Broto, J., Lopez Pousa, A., Grignani, G., . . . Casali, P. G. (2020). Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups. J Clin Oncol, 38(19), 2178-2186. https://doi.org/10.1200/jco.19.03289
Gronchi, A., Strauss, D. C., Miceli, R., Bonvalot, S., Swallow, C. J., Hohenberger, P., . . . Raut, C. P. (2016). Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group. Ann Surg, 263(5), 1002-1009. https://doi.org/10.1097/sla.0000000000001447
Grosso, F., Sanfilippo, R., Virdis, E., Piovesan, C., Collini, P., Dileo, P., . . . Casali, P. G. (2009). Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series. Ann Oncol, 20(8), 1439-1444.
Gustafson, P., Dreinhofer, K. E., & Rydholm, A. (1994). Soft tissue sarcoma should be treated at a tumor center. A comparison of quality of surgery in 375 patients. Acta Orthop Scand, 65(1), 47-50.
Gustafsson, U. O., Scott, M. J., Schwenk, W., Demartines, N., Roulin, D., Francis, N., . . . Nutrition. (2013). Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS()) Society recommendations. World Journal of Surgery, 37(2), 259-284.
Gyorki, D. E., & Brennan, M. F. (2014). Management of recurrent retroperitoneal sarcoma. Journal of Surgical Oncology, 109(1), 53-59. https://doi.org/10.1002/jso.23463
Habrand, J. L., Schneider, R., Alapetite, C., Feuvret, L., Petras, S., Datchary, J., . . . Sainte-Rose, C. (2008). Proton therapy in pediatric skull base and cervical canal low-grade bone malignancies. Int J Radiat Oncol Biol Phys, 71(3), 672-675. https://doi.org/10.1016/j.ijrobp.2008.02.043
Haibach, H., Farrell, C., & Dittrich, F. J. (1985). Neoplasms arising in Paget's disease of bone: a study of 82 cases. Am J Clin Pathol, 83(5), 594-600.
Hall, K. S., Bruland Ø, S., Bjerkehagen, B., Lidbrink, E., Jebsen, N., Hagberg, H., . . . Eriksson, M. (2020). Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study. Clinical sarcoma research, 10(1), 22. https://doi.org/10.1186/s13569-020-00145-5
Hardes, J., von Eiff, C., Streitbuerger, A., Balke, M., Budny, T., Henrichs, M. P., . . . Ahrens, H. (2010). Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma. Journal of Surgical Oncology, 101(5), 389-395. https://doi.org/10.1002/jso.21498
Hartmann, J. T., Kopp, H. G., Gruenwald, V., Piperno-Neumann, S., Kunitz, A., Hofheinz, R., . . . Mayer, F. (2020). Randomised phase II trial of trofosfamide vs. doxorubicin in elderly patients with untreated metastatic soft-tissue sarcoma. Eur J Cancer, 124, 152-160. https://doi.org/10.1016/j.ejca.2019.10.016
Hawkins, M. M., Wilson, L. M., Burton, H. S., Potok, M. H., Winter, D. L., Marsden, H. B., & Stovall, M. A. (1996). Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst, 88(5), 270-278.
Helse- og omsorgsdepartementet. (2015). Nasjonal helse- og sykehusplan (2016–2019) (Meld. St. 11 (2015–2016)). Hentet fra https://www.regjeringen.no/no/dokumenter/meld.-st.-11-20152016/id2462047/
Hensley, M. L., Maki, R., Venkatraman, E., Geller, G., Lovegren, M., Aghajanian, C., . . . Spriggs, D. R. (2002). Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol, 20(12), 2824-2831.
Heslin, M. J., Lewis, J. J., Nadler, E., Newman, E., Woodruff, J. M., Casper, E. S., . . . Brennan, M. F. (1997). Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol, 15(8), 2832-2839.
Higuchi, T., Yamamoto, N., Nishida, H., Hayashi, K., Takeuchi, A., Kimura, H., . . . Tsuchiya, H. (2017). Knee joint preservation surgery in osteosarcoma using tumour-bearing bone treated with liquid nitrogen. International orthopaedics, Jun 1 [Epub ahead of print]. https://doi.org/10.1007/s00264-017-3499-x
Hompland, I., Ferrari, S., Bielack, S., Palmerini, E., Hall, K. S., Picci, P., . . . Smeland, S. (2021). Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study. Eur J Cancer, 151, 150-158. https://doi.org/10.1016/j.ejca.2021.04.017
Hongtao, L., Hui, Z., Bingshun, W., Xiaojin, W., Zhiyu, W., Shuier, Z., . . . Yang, Y. (2012). 18F-FDG positron emission tomography for the assessment of histological response to neoadjuvant chemotherapy in osteosarcomas: a meta-analysis. Surgical Oncology, 21(4), e165-170. https://doi.org/10.1016/j.suronc.2012.07.002
Hough, A. (2001). Physiotherapy in respiratory care: an evidence-based approach to respiratory and cardiac management. Cheltenham: Trans-Atlantic Publications.
Huang, T., Li, F., Yan, Z., Ma, Y., Xiong, F., Cai, X., . . . Dong, J. (2018). Effectiveness of 18F-FDG PET/CT in the diagnosis, staging and recurrence monitoring of Ewing sarcoma family of tumors: A meta-analysis of 23 studies. Medicine (Baltimore), 97(48), e13457. https://doi.org/10.1097/MD.0000000000013457
Hug, E. B., Adams, J., Fitzek, M., De Vries, A., & Munzenrider, J. E. (2000). Fractionated, three-dimensional, planning-assisted proton-radiation therapy for orbital rhabdomyosarcoma: a novel technique. Int J Radiat Oncol Biol Phys, 47(4), 979-984.
Hung, E. H. Y., Griffith, J. F., Yip, S. W. Y., Ivory, M., Lee, J. C. H., Ng, A. W. H., & Tong, C. S. L. (2020). Accuracy of ultrasound in the characterization of superficial soft tissue tumors: a prospective study. Skeletal Radiology, 49(6), 883-892. https://doi.org/10.1007/s00256-019-03365-z
Hung, J., & Anderson, R. (1997). p53: functions, mutations and sarcomas. Acta Orthop Scand suppl, 273, 68-73.
Huvos, A. G., Butler, A., & Bretsky, S. S. (1983). Osteogenic sarcoma associated with Paget's disease of bone. A clinicopathologic study of 65 patients. Cancer, 52(8), 1489-1495.
Huvos, A. G., Sundaresan, N., Bretsky, S. S., & Butler, A. (1985). Osteogenic sarcoma of the skull. A clinicopathologic study of 19 patients. Cancer, 56(5), 1214-1221.
Hwang, J. P., Lim, I., Kong, C. B., Jeon, D. G., Byun, B. H., Kim, B. I., . . . Lim, S. M. (2016). Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma. PloS One, 11(4), e0153281. https://doi.org/10.1371/journal.pone.0153281
Hølmebakk, T., Bjerkehagen, B., Hompland, I., Stoldt, S., & Boye, K. (2019). Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour. British Journal of Surgery, 106(4), 419-426. https://doi.org/10.1002/bjs.11027
Hølmebakk, T., Hompland, I., Bjerkehagen, B., Stoldt, S., Bruland Ø, S., Hall, K. S., & Boye, K. (2018). Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study. Ann Surg Oncol, 25(5), 1133-1139. https://doi.org/10.1245/s10434-018-6353-5
Hølmebakk, T., Wiedswang, A. M., Meza-Zepeda, L. A., Hompland, I., Lobmaier, I. V. K., Berner, J. M., . . . Boye, K. (2021). Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the Stomach. Ann Surg Oncol, 28(11), 6837-6845. https://doi.org/10.1245/s10434-021-09605-8
Haas, R. L., Delaney, T. F., O'Sullivan, B., Keus, R. B., Le Pechoux, C., Olmi, P., . . . Wang, D. (2012). Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where? Int J Radiat Oncol Biol Phys, 84(3), 572-580. https://doi.org/10.1016/j.ijrobp.2012.01.062
Igaki, H., Tokuuye, K., Okumura, T., Sugahara, S., Kagei, K., Hata, M., . . . Akine, Y. (2004). Clinical results of proton beam therapy for skull base chordoma. Int J Radiat Oncol Biol Phys, 60(4), 1120-1126. https://doi.org/10.1016/j.ijrobp.2004.05.064
Igarashi, K., Yamamoto, N., Shirai, T., Hayashi, K., Nishida, H., Kimura, H., . . . Tsuchiya, H. (2014). The long-term outcome following the use of frozen autograft treated with liquid nitrogen in the management of bone and soft-tissue sarcomas. The bone & joint journal, 96-B(4), 555-561. https://doi.org/10.1302/0301-620X.96B4.32629
Issels, R., & Lindner, L. H. (2016). Regional hyperthermia for high-risk soft tissue sarcoma treatment: present status and next questions. Current Opinion in Oncology, 28(5), 447-452.
Issels, R. D., Lindner, L. H., Verweij, J., Wust, P., Reichardt, P., Schem, B. C., . . . European Society for Hyperthermic, O. (2010). Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncology, 11(6), 561-570.
An italian - scandinavian treatment protocol for metastatic and pelvic osteosarcoma (ISG/SSG II). (2002). Bologna; Lund: Italian sarcoma group (ISG), Scandinavian sarcoma group and oncologic center (SSG).
Jebsen, N. L., Bruland, Ø. S., Eriksson, M., Engellau, J., Turesson, I., Folin, A., . . . Hall, K. S. (2011). Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall. Int J Radiat Oncol Biol Phys, 81(5), 1359-1366. https://doi.org/10.1016/j.ijrobp.2010.07.037
Jebsen, N. L., Trovik, C. S., Bauer, H. C., Rydholm, A., Monge, O. R., Hall, K. S., . . . Bruland, O. S. (2008). Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: a Scandinavian sarcoma group study. Int J Radiat Oncol Biol Phys, 71(4), 1196-1203.
Jian, B. J., Bloch, O. G., Yang, I., Han, S. J., Aranda, D., Tihan, T., & Parsa, A. T. (2010). Adjuvant radiation therapy and chondroid chordoma subtype are associated with a lower tumor recurrence rate of cranial chordoma. J Neurooncol, 98(1), 101-108.
Jingu, K., Tsujii, H., Mizoe, J. E., Hasegawa, A., Bessho, H., Takagi, R., . . . Organizing Committee for the Working Group for Head-and-Neck, C. (2012). Carbon ion radiation therapy improves the prognosis of unresectable adult bone and soft-tissue sarcoma of the head and neck. International Journal of Radiation Oncology, Biology, Physics, 82(5), 2125-2131.
Joensuu, H. (2008). Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol, 39(10), 1411-1419.
Joensuu, H., Eriksson, M., Collan, J., Balk, M. H., Leyvraz, S., & Montemurro, M. (2015). Radiotherapy for GIST progressing during or after tyrosine kinase inhibitor therapy: A prospective study. Radiother Oncol, 116(2), 233-238. https://doi.org/10.1016/j.radonc.2015.07.025
Joensuu, H., Eriksson, M., Sundby Hall, K., Hartmann, J. T., Pink, D., Schutte, J., . . . Reichardt, P. (2012). One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA, 307(12), 1265-1272. https://doi.org/10.1001/jama.2012.347
Joensuu, H., Eriksson, M., Sundby Hall, K., Reichardt, A., Hartmann, J. T., Pink, D., . . . Reichardt, P. (2016). Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial. Journal of Clinical Oncology, 34(3), 244-250.
Joensuu, H., Eriksson, M., Sundby Hall, K., Reichardt, A., Hermes, B., Schütte, J., . . . Reichardt, P. (2020). Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial After 10-Year Follow-up. JAMA Oncol, 6(8), 1241-1246. https://doi.org/10.1001/jamaoncol.2020.2091
Joensuu, H., Hohenberger, P., & Corless, C. L. (2013). Gastrointestinal stromal tumour. Lancet, 382(9896), 973-983. https://doi.org/10.1016/s0140-6736(13)60106-3
Joensuu, H., Vehtari, A., Riihimaki, J., Nishida, T., Steigen, S. E., Brabec, P., . . . Rutkowski, P. (2012). Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. The Lancet. Oncology, 13(3), 265-274. https://doi.org/10.1016/s1470-2045(11)70299-6
Joensuu, H., Wardelmann, E., Sihto, H., Eriksson, M., Sundby Hall, K., Reichardt, A., . . . Reichardt, P. (2017). Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial. JAMA Oncol, 3(5), 602-609. https://doi.org/10.1001/jamaoncol.2016.5751
Jones, R. L., Serrano, C., von Mehren, M., George, S., Heinrich, M. C., Kang, Y. K., . . . Bauer, S. (2021). Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial. Eur J Cancer, 145, 132-142. https://doi.org/10.1016/j.ejca.2020.12.008
Jordhøy, M. S., Fayers, P., Loge, J. H., Ahlner-Elmqvist, M., & Kaasa, S. (2001). Quality of life in palliative cancer care: results from a cluster randomized trial. J Clin Oncol, 19(18), 3884-3894.
Judson, I., Verweij, J., Gelderblom, H., Hartmann, J. T., Schöffski, P., Blay, J. Y., . . . van der Graaf, W. T. (2014). Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. The Lancet. Oncology, 15(4), 415-423. https://doi.org/10.1016/s1470-2045(14)70063-4
Kamada, T., Tsujii, H., Tsuji, H., Yanagi, T., Mizoe, J. E., Miyamoto, T., . . . Soft Tissue, S. (2002). Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. Journal of Clinical Oncology, 20(22), 4466-4471.
Kang, Y. K., Ryu, M. H., Yoo, C., Ryoo, B. Y., Kim, H. J., Lee, J. J., . . . Demetri, G. D. (2013). Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, phase 3 trial. The Lancet. Oncology, 14(12), 1175-1182. https://doi.org/10.1016/s1470-2045(13)70453-4
Kepka, L., DeLaney, T. F., Suit, H. D., & Goldberg, S. I. (2005). Results of radiation therapy for unresected soft-tissue sarcomas. Int J Radiat Oncol Biol Phys, 63(3), 852-859.
Kinge, B., Tranheim, R. S., & Eide, N. A. (2004). Retinoblastom--arvelig øyekreft hos barn. [Retinoblastoma--hereditary eye cancer in children .]. Tidsskr Nor Lægeforen, 124(2), 183-185.
Koontz, B. F., Clough, R. W., & Halperin, E. C. (2006). Palliative radiation therapy for metastatic Ewing sarcoma. Cancer, 106(8), 1790-1793.
Kransdorf, M. J. (2009). Society of skeletal radiology 2008 annual meeting. Skeletal Radiology, 38(1), 97-100.
Kransdorf, M. J., & Murphey, M. D. (2000). Radiologic evaluation of soft-tissue masses: a current perspective. AJR Am J Roentgenol, 175(3), 575-587.
Kransdorf, M. J., & Murphey, M. D. (2006). Imaging of soft tissue tumors (2. utg.). Philadelphia, Pa.: Lippincott Williams & Wilkins.
Kubo, T., Furuta, T., Johan, M. P., & Ochi, M. (2016). Prognostic significance of (18)F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma; systematic review and meta-analysis. European Journal of Cancer, 58, 104-111.
Ladenstein, R., Pötschger, U., Le Deley, M. C., Whelan, J., Paulussen, M., Oberlin, O., . . . Jürgens, H. (2010). Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. J Clin Oncol, 28(20), 3284-3291. https://doi.org/10.1200/jco.2009.22.9864
Lagrange, J. L., Ramaioli, A., Chateau, M. C., Marchal, C., Resbeut, M., Richaud, P., . . . Coindre, J. M. (2000). Sarcoma after radiation therapy: retrospective multiinstitutional study of 80 histologically confirmed cases. Radiation Therapist and Pathologist Groups of the Federation Nationale des Centres de Lutte Contre le Cancer. Radiology, 216(1), 197-205.
Lakkaraju, A., Sinha, R., Garikipati, R., Edward, S., & Robinson, P. (2009). Ultrasound for initial evaluation and triage of clinically suspicious soft-tissue masses. Clinical Radiology, 64(6), 615-621. https://doi.org/10.1016/j.crad.2009.01.012
Lansu, J., Bovée, J., Braam, P., van Boven, H., Flucke, U., Bonenkamp, J. J., . . . Haas, R. L. (2021). Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial. JAMA Oncol, 7(1), e205865. https://doi.org/10.1001/jamaoncol.2020.5865
Le Cesne, A., Antoine, E., Spielmann, M., Le Chevalier, T., Brain, E., Toussaint, C., . . . et al. (1995). High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas. J Clin Oncol, 13(7), 1600-1608. https://doi.org/10.1200/jco.1995.13.7.1600
Le Cesne, A., Blay, J. Y., Judson, I., Van, O. A., Verweij, J., Radford, J., . . . Nielsen, O. S. (2005). Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial. J Clin Oncol, 23(3), 576-584.
Le Cesne, A., Ray-Coquard, I., Bui, B. N., Adenis, A., Rios, M., Bertucci, F., . . . Blay, J. Y. (2010). Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial. The Lancet. Oncology, 11(10), 942-949. https://doi.org/10.1016/s1470-2045(10)70222-9
Lee, A. Y., Rickles, F. R., Julian, J. A., Gent, M., Baker, R. I., Bowden, C., . . . Levine, M. N. (2005). Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J Clin Oncol, 23(10), 2123-2129.
Lee, C. T., Bilton, S. D., Famiglietti, R. M., Riley, B. A., Mahajan, A., Chang, E. L., . . . Smith, A. R. (2005). Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys, 63(2), 362-372. https://doi.org/10.1016/j.ijrobp.2005.01.060
Levernes, S., & Johannessen, D. C. (2003). Volum og doser ved strålebehandling: definisjoner, retningslinjer for bruk, dokumentasjon og rapportering (StrålevernRapport 2003:12). Østerås: Statens Strålevern. Hentet fra https://dsa.no/publikasjoner/stralevernrapport-12-2003-volum-og-doser-ved-stralebehandling/straalevernrapport-2003-12-volum-og-doser-ved-straalebehandling-definisjoner-retningslinjer-dokumentasjon-rapportering.pdf
Lewis, J. J., Leung, D., Woodruff, J. M., & Brennan, M. F. (1998). Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg, 228(3), 355-365.
Li, F. P., & Fraumeni, J. F., Jr. (1969). Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med, 71(4), 747-752.
Li, Y. J., Dai, Y. L., Cheng, Y. S., Zhang, W. B., & Tu, C. Q. (2016). Positron emission tomography (18)F-fluorodeoxyglucose uptake and prognosis in patients with bone and soft tissue sarcoma: A meta-analysis. Eur J Surg Oncol, 42(8), 1103-1114. https://doi.org/10.1016/j.ejso.2016.04.056
Lim, H. J., Johnny Ong, C. A., Tan, J. W., & Ching Teo, M. C. (2019). Utility of positron emission tomography/computed tomography (PET/CT) imaging in the evaluation of sarcomas: A systematic review. Critical Reviews in Oncology/Hematology, 143, 1-13. https://doi.org/10.1016/j.critrevonc.2019.07.002
Liu, F., Zhang, Q., Zhou, D., & Dong, J. (2019). Effectiveness of (18)F-FDG PET/CT in the diagnosis and staging of osteosarcoma: a meta-analysis of 26 studies. BMC Cancer, 19(1), 323. https://doi.org/10.1186/s12885-019-5488-5
Liu, J., Hudkins, P. G., Swee, R. G., & Unni, K. K. (1987). Bone sarcomas associated with Ollier's disease. Cancer, 59(7), 1376-1385.
Longhi, A., Paioli, A., Palmerini, E., Cesari, M., Abate, M. E., Setola, E., . . . Boye, K. (2019). Pazopanib in relapsed osteosarcoma patients: report on 15 cases. Acta oncologica (Stockholm, Sweden), 58(1), 124-128. https://doi.org/10.1080/0284186x.2018.1503714
Lov om folketrygd (folketrygdloven). LOV-1997-02-28-19. Sist endret i LOV-2021-12-22-151 fra 01.01.2022. Hentet fra https://lovdata.no/dokument/NL/lov/1997-02-28-19
Lov om pasient- og brukerrettigheter (pasient- og brukerrettighetsloven). LOV-1999-07-02-63. Sist endret i LOV-2021-05-07-31 fra 01.07.2021. Hentet fra https://lovdata.no/dokument/NL/lov/1999-07-02-63
Luksch, R., Tienghi, A., Hall, K. S., Fagioli, F., Picci, P., Barbieri, E., . . . Ferrari, S. (2012). Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation. Ann Oncol, 23(11), 2970-2976. https://doi.org/10.1093/annonc/mds117
Ma, L. D., McCarthy, E. F., Bluemke, D. A., & Frassica, F. J. (1998). Differentiation of benign from malignant musculoskeletal lesions using MR imaging: pitfalls in MR evaluation of lesions with a cystic appearance. AJR Am J Roentgenol, 170(5), 1251-1258.
Macpherson, R. E., Pratap, S., Tyrrell, H., Khonsari, M., Wilson, S., Gibbons, M., . . . Hassan, A. B. (2018). Retrospective audit of 957 consecutive (18)F-FDG PET-CT scans compared to CT and MRI in 493 patients with different histological subtypes of bone and soft tissue sarcoma. Clinical sarcoma research, 8, 9. https://doi.org/10.1186/s13569-018-0095-9
Malkin, D., Jolly, K. W., Barbier, N., Look, A. T., Friend, S. H., Gebhardt, M. C., . . . . (1992). Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med, 326(20), 1309-1315.
Mankin, H. J., Lange, T. A., & Spanier, S. S. (1982). The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. J Bone Joint Surg Am, 64(8), 1121-1127.
Marina, N. M., Smeland, S., Bielack, S. S., Bernstein, M., Jovic, G., Krailo, M. D., . . . Whelan, J. S. (2016). Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. Lancet Oncology, 17(10), 1396-1408.
Markhede, G., & Stener, B. (1981). Function after removal of various hip and thigh muscles for extirpation of tumors. Acta Orthop Scand, 52(4), 373-395.
Marks, L. B., Yorke, E. D., Jackson, A., Ten Haken, R. K., Constine, L. S., Eisbruch, A., . . . Deasy, J. O. (2010). Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys, 76(3 Suppl), S10-19. https://doi.org/10.1016/j.ijrobp.2009.07.1754
Menu-Branthomme, A., Rubino, C., Shamsaldin, A., Hawkins, M. M., Grimaud, E., Dondon, M. G., . . . de Vathaire, F. (2004). Radiation dose, chemotherapy and risk of soft tissue sarcoma after solid tumours during childhood. International Journal of Cancer, 110(1), 87-93.
Meyers, P. A., Schwartz, C. L., Krailo, M. D., Healey, J. H., Bernstein, M. L., Betcher, D., . . . Children's Oncology, G. (2008). Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. Journal of Clinical Oncology, 26(4), 633-638.
Miettinen, M., & Lasota, J. (2006). Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol, 23(2), 70-83. https://doi.org/10.1053/j.semdp.2006.09.001
Milano, M. T., Constine, L. S., & Okunieff, P. (2007). Normal tissue tolerance dose metrics for radiation therapy of major organs. Semin Radiat Oncol, 17(2), 131-140.
Miller, T. T. (2008). Bone tumors and tumorlike conditions: analysis with conventional radiography. Radiology, 246(3), 662-674.
Mir, O., Cropet, C., Toulmonde, M., Cesne, A. L., Molimard, M., Bompas, E., . . . Osseuses, P. s. g. o. t. F. S. G.-G. d. E. d. T. (2016). Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial. The Lancet. Oncology, 17(5), 632-641. https://doi.org/10.1016/S1470-2045(16)00075-9
Miralbell, R., Lomax, A., Cella, L., & Schneider, U. (2002). Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys, 54(3), 824-829.
Mizumoto, M., Murayama, S., Akimoto, T., Demizu, Y., Fukushima, T., Ishida, Y., . . . Sakurai, H. (2018). Preliminary results of proton radiotherapy for pediatric rhabdomyosarcoma: a multi-institutional study in Japan. Cancer Med, 7(5), 1870-1874. https://doi.org/10.1002/cam4.1464
Morgan, E. A., Kozono, D. E., Wang, Q., Mery, C. M., Butrynski, J. E., Baldini, E. H., . . . Raut, C. P. (2012). Cutaneous radiation-associated angiosarcoma of the breast: poor prognosis in a rare secondary malignancy. Ann Surg Oncol, 19(12), 3801-3808. https://doi.org/10.1245/s10434-012-2563-4
Moser, R. P., Jr., & Madewell, J. E. (1987). An approach to primary bone tumors. Radiol Clin North Am, 25(6), 1049-1093.
Moulton, J. S., Blebea, J. S., Dunco, D. M., Braley, S. E., Bisset, G. S., III, & Emery, K. H. (1995). MR imaging of soft-tissue masses: diagnostic efficacy and value of distinguishing between benign and malignant lesions. AJR Am J Roentgenol, 164(5), 1191-1199.
Mucciarini, C., Rossi, G., Bertolini, F., Valli, R., Cirilli, C., Rashid, I., . . . Federico, M. (2007). Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study. BMC Cancer, 7, 230. https://doi.org/10.1186/1471-2407-7-230
Murray, E. M., Werner, D., Greeff, E. A., & Taylor, D. A. (1999). Postradiation sarcomas: 20 cases and a literature review. Int J Radiat Oncol Biol Phys, 45(4), 951-961.
Nasjonale faglige retningslinjer for forebygging og behandling av underernæring. (2009). (IS-1580). Oslo: Helsedirektoratet. Hentet fra http://helsedirektoratet.no/publikasjoner/nasjonal-faglig-retningslinje-for-forebygging-og-behandling-av-underernering/Publikasjoner/nasjonal-faglig-retningslinje-for-forebygging-og-behandling-av-underernering.PDF
Nasjonalt handlingsprogram for palliasjon i kreftomsorgen: nasjonal faglig retningslinje. (2019). (rev utg.). (IS-2800). Oslo: Helsedirektoratet. Hentet fra https://www.helsedirektoratet.no/retningslinjer/palliasjon-i-kreftomsorgen-handlingsprogram
Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av kreft hos barn: nasjonal faglig retningslinje. (2020). (IS-2925). Oslo: Helsedirektoratet. Hentet fra https://www.helsedirektoratet.no/retningslinjer/kreft-hos-barn-handlingsprogram
Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av maligne lymfomer. (2012). (rev utg.). (IS-1594). Oslo: Helsedirektoratet. Hentet fra http://www.helsedirektoratet.no/publikasjoner/nasjonalt-handlingsprogram-med-retningslinjer-for-diagnostikk-behandling-og-oppfolging-av-maligne-lymfomer/Sider/default.aspx
Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av pasienter med brystkreft: nasjonal faglig retningslinje. (2021). (rev. utg.). (IS-3012). Oslo: Helsedirektoratet. Hentet fra https://www.helsedirektoratet.no/retningslinjer/brystkreft-handlingsprogram
Noel, G., Feuvret, L., Calugaru, V., Dhermain, F., Mammar, H., Haie-Meder, C., . . . Mazeron, J. J. (2005). Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams. Acta oncologica (Stockholm, Sweden), 44(7), 700-708. https://doi.org/10.1080/02841860500326257
Noel, G., Habrand, J. L., Jauffret, E., de Crevoisier, R., Dederke, S., Mammar, H., . . . Mazeron, J. J. (2003). Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and patterns of failure. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 179(4), 241-248. https://doi.org/10.1007/s00066-003-1065-5
Nordal, R. R. (1998). Uterine sarcomas in Norway 1956-1992: an epidemiological and clinicopathological study (doktorgrad). Oslo: Faculty of Medicine, University of Oslo.
O'Sullivan, B., Davis, A. M., Turcotte, R., Bell, R., Catton, C., Chabot, P., . . . Zee, B. (2002). Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet, 359(9325), 2235-2241.
O'Sullivan, B., Wylie, J., Catton, C., Gutierrez, E., Swallow, C. J., Wunder, J., . . . Bell, R. (1999). The local management of soft tissue sarcoma. Semin Radiat Oncol, 9(4), 328-348.
Oberlin, O., Rey, A., Desfachelles, A. S., Philip, T., Plantaz, D., Schmitt, C., . . . Michon, J. (2006). Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant. J Clin Oncol, 24(24), 3997-4002. https://doi.org/10.1200/jco.2006.05.7059
Palmerini, E., Colangeli, M., Nanni, C., Fanti, S., Marchesi, E., Paioli, A., . . . Ferrari, S. (2017). The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas. European journal of nuclear medicine and molecular imaging, 44(2), 215-223. https://doi.org/10.1007/s00259-016-3509-z
Palmerini, E., Jones, R. L., Marchesi, E., Paioli, A., Cesari, M., Longhi, A., . . . Ferrari, S. (2016). Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone. BMC Cancer, 16, 280. https://doi.org/10.1186/s12885-016-2312-3
Parker, W. H., Fu, Y. S., & Berek, J. S. (1994). Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol, 83(3), 414-418.
Pasquali, S., Pizzamiglio, S., Touati, N., Litiere, S., Marreaud, S., Kasper, B., . . . Gronchi, A. (2019). The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial. Eur J Cancer, 109, 51-60. https://doi.org/10.1016/j.ejca.2018.12.009
Penel, N., Bui, B. N., Bay, J. O., Cupissol, D., Ray-Coquard, I., Piperno-Neumann, S., . . . Blay, J. Y. (2008). Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol, 26(32), 5269-5274.
Pervaiz, N., Colterjohn, N., Farrokhyar, F., Tozer, R., Figueredo, A., & Ghert, M. (2008). A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer, 113(3), 573-581.
Petasnick, J. P., Turner, D. A., Charters, J. R., Gitelis, S., & Zacharias, C. E. (1986). Soft-tissue masses of the locomotor system: comparison of MR imaging with CT. Radiology, 160(1), 125-133.
Physiotherapy for respiratory and cardiac problems: adults and paediatrics. (2008). Edinburgh: Churchill Livingstone Elsevier.
Pisters, P. W., O'Sullivan, B., & Maki, R. G. (2007). Evidence-based recommendations for local therapy for soft tissue sarcomas. J Clin Oncol, 25(8), 1003-1008.
Pisters, P. W. T. (2002). Retroperitoneal sarcomas. I: R. E. Pollock (red.), Soft tissue sarcomas (s. 180-188). Hamilton: Decker.
Pårørendeveileder. (28.01.2019). [nettdokument]. Oslo: Helsedirektoratet. Hentet 31.01.2022, fra https://www.helsedirektoratet.no/veiledere/parorendeveileder
Rakheja, R., Makis, W., Skamene, S., Nahal, A., Brimo, F., Azoulay, L., . . . Hickeson, M. (2012). Correlating metabolic activity on 18F-FDG PET/CT with histopathologic characteristics of osseous and soft-tissue sarcomas: a retrospective review of 136 patients. AJR Am J Roentgenol, 198(6), 1409-1416. https://doi.org/10.2214/AJR.11.7560
Riedel, R. F., Larrier, N., Dodd, L., Kirsch, D., Martinez, S., & Brigman, B. E. (2009). The clinical management of chondrosarcoma. Curr Treat Options Oncol, 10(1-2), 94-106.
Roberge, D., Vakilian, S., Alabed, Y. Z., Turcotte, R. E., Freeman, C. R., & Hickeson, M. (2012). FDG PET/CT in Initial Staging of Adult Soft-Tissue Sarcoma. Sarcoma, 2012, 960194. https://doi.org/10.1155/2012/960194
Robertson, E. G., & Baxter, G. (2011). Tumour seeding following percutaneous needle biopsy: the real story! Clinical Radiology, 66(11), 1007-1014. https://doi.org/10.1016/j.crad.2011.05.012
Rombi, B., DeLaney, T. F., MacDonald, S. M., Huang, M. S., Ebb, D. H., Liebsch, N. J., . . . Yock, T. I. (2012). Proton radiotherapy for pediatric Ewing's sarcoma: initial clinical outcomes. Int J Radiat Oncol Biol Phys, 82(3), 1142-1148. https://doi.org/10.1016/j.ijrobp.2011.03.038
Rosenberg, A. E., Nielsen, G. P., Keel, S. B., Renard, L. G., Fitzek, M. M., Munzenrider, J. E., & Liebsch, N. J. (1999). Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am J Surg Pathol, 23(11), 1370-1378.
Rowbotham, E., Bhuva, S., Gupta, H., & Robinson, P. (2012). Assessment of referrals into the soft tissue sarcoma service: evaluation of imaging early in the pathway process. Sarcoma, 2012, 781723. https://doi.org/10.1155/2012/781723
Rydholm, A. (1998). Improving the management of soft tissue sarcoma. Diagnosis and treatment should be given in specialist centres. BMJ, 317(7151), 93-94.
Salunke, A. A., Chen, Y., Tan, J. H., Chen, X., Khin, L. W., & Puhaindran, M. E. (2014). Does a pathological fracture affect the prognosis in patients with osteosarcoma of the extremities? : a systematic review and meta-analysis. The bone & joint journal, 96-B(10), 1396-1403. https://doi.org/10.1302/0301-620X.96B10.34370
Sarkom. (23.08. 2018 ). I: Pakkeforløp for kreft - Diagnoseveiledere. [nettdokument]. Oslo: Helsedirektoratet. Hentet 31.01.2022
Schmidt-Braekling, T., Streitbuerger, A., Gosheger, G., Boettner, F., Nottrott, M., Ahrens, H., . . . Hardes, J. (2017). Silver-coated megaprostheses: review of the literature. European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 27(4), 483-489. https://doi.org/10.1007/s00590-017-1933-9
Schwartz, H. S., Zimmerman, N. B., Simon, M. A., Wroble, R. R., Millar, E. A., & Bonfiglio, M. (1987). The malignant potential of enchondromatosis. J Bone Joint Surg Am, 69(2), 269-274.
Schöffski, P., Chawla, S., Maki, R. G., Italiano, A., Gelderblom, H., Choy, E., . . . Patel, S. R. (2016). Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial. Lancet, 387(10028), 1629-1637. https://doi.org/10.1016/s0140-6736(15)01283-0
Seddon, B., Strauss, S. J., Whelan, J., Leahy, M., Woll, P. J., Cowie, F., . . . Beare, S. (2017). Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial. The Lancet. Oncology, Sep 4 [Epub ahead of print]. https://doi.org/10.1016/s1470-2045(17)30622-8
Seneffekter etter kreftbehandling. (2020). (IS-2872). Oslo: Helsedirektoratet. Hentet fra https://www.helsedirektoratet.no/rapporter/seneffekter-etter-kreftbehandling/Seneffekter%20etter%20kreftbehandling.pdf/_/attachment/inline/3d984c2a-7926-4d1a-a5f0-06d48fe7c95f:f3e498d059734ff34b013c1c206877e488e95600/Seneffekter%20etter%20kreftbehandling.pdf
Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma. (2021-2034). [pågående studie]. (NCT04776525). Hentet fra https://clinicaltrials.gov/ct2/show/NCT04776525
Sleijfer, S., Ray-Coquard, I., Papai, Z., Le Cesne, A., Scurr, M., Schoffski, P., . . . Blay, J. Y. (2009). Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043). J Clin Oncol, 27(19), 3126-3132. https://doi.org/10.1200/jco.2008.21.3223
Smith, H. G., Cartwright, J., Wilkinson, M. J., Strauss, D. C., Thomas, J. M., & Hayes, A. J. (2015). Isolated Limb Perfusion with Melphalan and Tumour Necrosis Factor alpha for In-Transit Melanoma and Soft Tissue Sarcoma. Annals of Surgical Oncology, 22 Suppl 3, S356-361.
Smith, L. M., & Donaldson, S. S. (1991). Incidence and management of secondary malignancies in patients with retinoblastoma and Ewing's sarcoma. Oncology (Williston Park, N.Y.), 5(5), 135-141; discussion 142.
Smith, M. J., Ridgway, P. F., Catton, C. N., Cannell, A. J., O'Sullivan, B., Mikula, L. A., . . . Swallow, C. J. (2014). Combined management of retroperitoneal sarcoma with dose intensification radiotherapy and resection: long-term results of a prospective trial. Radiother Oncol, 110(1), 165-171. https://doi.org/10.1016/j.radonc.2013.10.041
Souba, W. W., McKenna, R. J., Jr., Meis, J., Benjamin, R., Raymond, A. K., & Mountain, C. F. (1986). Radiation-induced sarcomas of the chest wall. Cancer, 57(3), 610-615.
SSG XXV: The Stop-GIST Trial; Discontinuation of Imatinib in Patients With Oligo-metastatic GIST. (2016-2022). [pågående studie]. (NCT02924714). Hentet fra https://clinicaltrials.gov/ct2/show/NCT02924714
Stacchiotti, S., Tortoreto, M., Bozzi, F., Tamborini, E., Morosi, C., Messina, A., . . . Casali, P. G. (2013). Dacarbazine in solitary fibrous tumor: a case series analysis and preclinical evidence vis-a-vis temozolomide and antiangiogenics. Clinical cancer research : an official journal of the American Association for Cancer Research, 19(18), 5192-5201. https://doi.org/10.1158/1078-0432.Ccr-13-0776
Stoeckle, E., Coindre, J. M., Bonvalot, S., Kantor, G., Terrier, P., Bonichon, F., . . . French Federation of Cancer Centers Sarcoma, G. (2001). Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer, 92(2), 359-368.
Stoldt, H. S., & Geraghty, J. G. (1999). Surgical principles in the management of soft tissue sarcomas. I: I. Taylor & C. D. Johnson (red.), Recent advances in surgery (s. 47-61). London: Royal Society of Medicine Press.
Strander, H., Bauer, H. C., Brosjö, O., Fernberg, J. O., Kreicbergs, A., Nilsonne, U., . . . Söderlund, V. (1995). Long-term adjuvant interferon treatment of human osteosarcoma. A pilot study. Acta oncologica (Stockholm, Sweden), 34(6), 877-880.
Strander, H., & Einhorn, S. (1977). Effect of human leukocyte interferon on the growth of human osteosarcoma cells in tissue culture. Int J Cancer, 19(4), 468-473.
Strauss, S. J., Frezza, A. M., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., . . . Stacchiotti, S. (2021). Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol, 32(12), 1520-1536. https://doi.org/10.1016/j.annonc.2021.08.1995
Suit, H., Kooy, H., Trofimov, A., Farr, J., Munzenrider, J., DeLaney, T., . . . Paganetti, H. (2008). Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. Radiother Oncol, 86(2), 148-153. https://doi.org/10.1016/j.radonc.2007.12.024
Sundby Hall, K., Bruland Ø, S., Bjerkehagen, B., Zaikova, O., Engellau, J., Hagberg, O., . . . Eriksson, M. (2018). Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX). Eur J Cancer, 99, 78-85. https://doi.org/10.1016/j.ejca.2018.05.011
Surgery With Our Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma (STRASS2). (2019-2028). [pågående studie]. (NCT04031677). Hentet fra https://clinicaltrials.gov/ct2/show/NCT04031677
Swanson, E. L., Indelicato, D. J., Louis, D., Flampouri, S., Li, Z., Morris, C. G., . . . Slopsema, R. (2012). Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas. Int J Radiat Oncol Biol Phys, 83(5), 1549-1557. https://doi.org/10.1016/j.ijrobp.2011.10.014
Tangvik, R. J., Tell, G. S., Guttormsen, A. B., Eisman, J. A., Henriksen, A., Nilsen, R. M., & Ranhoff, A. H. (2015). Nutritional risk profile in a university hospital population. Clinical Nutrition, 34(4), 705-711.
Tawbi, H. A., Burgess, M., Bolejack, V., Van Tine, B. A., Schuetze, S. M., Hu, J., . . . Patel, S. (2017). Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. The Lancet. Oncology, 18(11), 1493-1501. https://doi.org/10.1016/s1470-2045(17)30624-1
Tehranzadeh, J., Mnaymneh, W., Ghavam, C., Morillo, G., & Murphy, B. J. (1989). Comparison of CT and MR imaging in musculoskeletal neoplasms. J Comput Assist Tomogr, 13(3), 466-472.
Thomas, H., & Timmermann, B. (2020). Paediatric proton therapy. British Journal of Radiology, 93(1107), 20190601. https://doi.org/10.1259/bjr.20190601
Thoresen, S. O. (1992). Li-Fraumeni-syndromet og p53-genet. Tidsskr Nor Lægeforen, 112(7), 887-889.
Toguchida, J., Yamaguchi, T., Dayton, S. H., Beauchamp, R. L., Herrera, G. E., Ishizaki, K., . . . Sasaki, M. S. (1992). Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. New England Journal of Medicine, 326(20), 1301-1308.
Toulmonde, M., Bonvalot, S., Méeus, P., Stoeckle, E., Riou, O., Isambert, N., . . . Italiano, A. (2014). Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Ann Oncol, 25(3), 735-742. https://doi.org/10.1093/annonc/mdt577
Travis, L. B., Rabkin, C. S., Brown, L. M., Allan, J. M., Alter, B. P., Ambrosone, C. B., . . . Greene, M. H. (2006). Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst, 98(1), 15-25.
Trovik, C., Bauer, H. C. F., Styring, E., Sundby Hall, K., Vult Von Steyern, F., Eriksson, S., . . . Alvegard, T. A. (2017). The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma. Acta orthopaedica, 88(3), 341-347. https://doi.org/10.1080/17453674.2017.1293441
Trovik, C. S., Bauer, H. C., Berlin, O., Tukiainen, E., Erlanson, M., Gustafson, P., . . . Wahlstrom, O. (2001). Local recurrence of deep-seated, high-grade, soft tissue sarcoma: 459 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand, 72(2), 160-166.
Trovik, L. H., Ovrebo, K., Almquist, M., Haugland, H. K., Rissler, P., Eide, J., . . . Jebsen, N. L. (2014). Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients. Acta Oncologica, 53(9), 1165-1172.
Tsuchiya, T., Sekine, K., Hinohara, S., Namiki, T., Nobori, T., & Kaneko, Y. (2000). Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma. Cancer Genet Cytogenet, 120(2), 91-98.
Uhl, M., Edler, L., Jensen, A. D., Habl, G., Oelmann, J., Röder, F., . . . Herfarth, K. (2014). Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol. Radiation oncology, 9, 100. https://doi.org/10.1186/1748-717X-9-100
Upubliserte data.
van der Graaf, W. T., Blay, J. Y., Chawla, S. P., Kim, D. W., Bui-Nguyen, B., Casali, P. G., . . . Hohenberger, P. (2012). Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet, 379(9829), 1879-1886. https://doi.org/10.1016/s0140-6736(12)60651-5
Van Glabbeke, M., Verweij, J., Judson, I., & Nielsen, O. S. (2002). Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas. Eur J Cancer, 38(4), 543-549. https://doi.org/10.1016/s0959-8049(01)00398-7
van Houdt, W. J., NS, I. J., Marjolein Schrijver, A., Huis In 't Veld, E., Thway, K., Jones, R. L., . . . Smith, M. J. F. (2021). Oncological Outcome After Diagnostic Biopsies in Gastrointestinal Stromal Tumors: A Retrospective Cohort Study. Ann Surg, 274(6), e1093-e1098. https://doi.org/10.1097/sla.0000000000003744
van Houdt, W. J., Raut, C. P., Bonvalot, S., Swallow, C. J., Haas, R., & Gronchi, A. (2019). New research strategies in retroperitoneal sarcoma. The case of TARPSWG, STRASS and RESAR: making progress through collaboration. Current Opinion in Oncology, 31(4), 310-316. https://doi.org/10.1097/cco.0000000000000535
Van Winkle, P., Angiolillo, A., Krailo, M., Cheung, Y. K., Anderson, B., Davenport, V., . . . Cairo, M. S. (2005). Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience. Pediatric blood & cancer, 44(4), 338-347. https://doi.org/10.1002/pbc.20227
Vincenzi, B., Napolitano, A., Fiocco, M., Mir, O., Rutkowski, P., Blay, J. Y., . . . Casali, P. G. (2021). Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study. Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.Ccr-21-1665
Wafa, H., Grimer, R. J., Reddy, K., Jeys, L., Abudu, A., Carter, S. R., & Tillman, R. M. (2015). Retrospective evaluation of the incidence of early periprosthetic infection with silver-treated endoprostheses in high-risk patients: case-control study. The bone & joint journal, 97-B(2), 252-257. https://doi.org/10.1302/0301-620X.97B2.34554
Wang, D., Bosch, W., Roberge, D., Finkelstein, S. E., Petersen, I., Haddock, M., . . . DeLaney, T. F. (2011). RTOG sarcoma radiation oncologists reach consensus on gross tumor volume and clinical target volume on computed tomographic images for preoperative radiotherapy of primary soft tissue sarcoma of extremity in Radiation Therapy Oncology Group studies. Int J Radiat Oncol Biol Phys, 81(4), e525-528. https://doi.org/10.1016/j.ijrobp.2011.04.038
Weatherall, P. T. (1995). Benign and malignant masses. MR imaging differentiation. Magn Reson Imaging Clin N Am, 3(4), 669-694.
Weber, D. C., Murray, F. R., Correia, D., Bolsi, A., Frei-Welte, M., Pica, A., . . . Bachtiary, B. (2017). Pencil beam scanned protons for the treatment of patients with Ewing sarcoma. Pediatric blood & cancer, 64(12). https://doi.org/10.1002/pbc.26688
Weber, D. C., Trofimov, A. V., Delaney, T. F., & Bortfeld, T. (2004). A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas. Int J Radiat Oncol Biol Phys, 58(5), 1596-1606. https://doi.org/10.1016/j.ijrobp.2003.11.028
Whelan, J., Le Deley, M. C., Dirksen, U., Le Teuff, G., Brennan, B., Gaspar, N., . . . Oberlin, O. (2018). High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008. J Clin Oncol, 36(31), Jco2018782516. https://doi.org/10.1200/jco.2018.78.2516
WHO Classification of Tumours Editorial Board (red.). (2020). WHO Classification of Tumours of Soft Tissue and Bone (5. utg.). (WHO Classification of Tumours, Volume 3). Geneva: WHO.
Wick, M. R., Siegal, G. P., Unni, K. K., McLeod, R. A., & Greditzer, H. G., III. (1981). Sarcomas of bone complicating osteitis deformans (Paget's disease): fifty years' experience. Am J Surg Pathol, 5(1), 47-59.
Widhe, B., & Widhe, T. (2000). Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma. J Bone Joint Surg Am, 82(5), 667-674.
Wilky, B. A., Trucco, M. M., Subhawong, T. K., Florou, V., Park, W., Kwon, D., . . . Trent, J. C. (2019). Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial. The Lancet. Oncology, 20(6), 837-848. https://doi.org/10.1016/s1470-2045(19)30153-6
Wittekind, C., Compton, C. C., Greene, F. L., & Sobin, L. H. (2002). TNM residual tumor classification revisited. Cancer, 94(9), 2511-2516.
Wolfson, A. H., Benedetto, P. W., Mnaymneh, W., Moffat, F. L., Robinson, D. S., Boyer, C., . . . Markoe, A. M. (1998). Does a radiation dose-response relation exist concerning survival of patients who have soft-tissue sarcomas of the extremities? Radiation dose-response relation for soft-tissue sarcomas. Am J Clin Oncol, 21(3), 270-274.
Woll, P. J., Reichardt, P., Le Cesne, A., Bonvalot, S., Azzarelli, A., Hoekstra, H. J., . . . the, N. C. T. G. S. D. S. C. (2012). Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncology, 13(10), 1045-1054.
Yang, J. C., Chang, A. E., Baker, A. R., Sindelar, W. F., Danforth, D. N., Topalian, S. L., . . . Rosenberg, S. A. (1998). Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol, 16(1), 197-203.
Yap, J., Chuba, P. J., Thomas, R., Aref, A., Lucas, D., Severson, R. K., & Hamre, M. (2002). Sarcoma as a second malignancy after treatment for breast cancer. Int J Radiat Oncol Biol Phys, 52(5), 1231-1237.
Zagars, G. K., & Ballo, M. T. (2003). Significance of dose in postoperative radiotherapy for soft tissue sarcoma. Int J Radiat Oncol Biol Phys, 56(2), 473-481.
Zaikova, O., Sundby Hall, K., Styring, E., Eriksson, M., Trovik, C. S., Bergh, P., . . . Bauer, H. C. (2015). Referral patterns, treatment and outcome of high-grade malignant bone sarcoma in Scandinavia--SSG Central Register 25 years' experience. Journal of Surgical Oncology, 112(8), 853-860.
Zalcberg, J. R., Verweij, J., Casali, P. G., Le Cesne, A., Reichardt, P., Blay, J. Y., . . . Australasian Gastrointestinal Trials, G. (2005). Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg. European Journal of Cancer, 41(12), 1751-1757.
Zhou, H., Coffin, C. M., Perkins, S. L., Tripp, S. R., Liew, M., & Viskochil, D. H. (2003). Malignant peripheral nerve sheath tumor: a comparison of grade, immunophenotype, and cell cycle/growth activation marker expression in sporadic and neurofibromatosis 1-related lesions. Am J Surg Pathol, 27(10), 1337-1345.